Recent Company News

• 09:21 AM ET Aug 24, 2025
  

  Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO

• 11:05 PM ET Aug 23, 2025
  

  ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

• 08:52 PM ET Aug 22, 2025
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 08:36 AM ET Aug 22, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:03 PM ET Aug 21, 2025
  

  NVO INVESTOR NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO

• 05:16 PM ET Aug 21, 2025
  

  SHAREHOLDER ALERT: Berger Montague Reminds Novo Nordisk A/S (NVO) Investors of Class Action Lawsuit Deadline

• 04:40 PM ET Aug 21, 2025
  

  Investor Alert: Deadline Approaching to Join Novo Nordisk A/S (NVO) Class Action - Contact Levi & Korsinsky

• 12:22 PM ET Aug 20, 2025
  

  NOVO NORDISK A/S SECURITIES FRAUD NOTICE: Berger Montague Informs Novo Nordisk A/S (NVO) Investors of Securities Fraud Lawsuit

• 02:03 AM ET Aug 20, 2025
  

  European macro headlines:

• 09:19 PM ET Aug 19, 2025
  

  INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk